News & Insights

Industry analysis, market trends, and policy updates for biologic medications and specialty pharmacy

Analysis and commentary on specialty pharmacy trends, biosimilar market developments, healthcare policy, and innovations in biologic therapy — from the BiologicHealthPlus team.

📰

2026-07-01

The Post-Humira Era: How Biosimilar Competition Is Changing Specialty Pharmacy

Humira lost US patent exclusivity in 2023, opening the door to eight biosimilars. Here's what this landmark shift means for patients, prescribers, and specialty pharmacies in 2026.

⚖️

2026-07-08

What Are PBM Rebate Walls? How They Affect Biologic Access | BiologicHealthPlus

Pharmacy Benefit Manager rebate walls are a key reason biosimilar adoption in the US has been slower than expected. Learn how PBMs work, what rebate walls are, and how they affect patient access to biologic medications.

📊

2026-07-15

Specialty Pharmacy Trends in 2026 | BiologicHealthPlus

Key trends shaping specialty pharmacy in 2026 — biosimilar adoption, GLP-1 growth, AI in prior authorization, home infusion expansion, and the future of biologic delivery.

💊 Stay Ahead with BiologicHealthPlus

Our pharmacists monitor formulary changes, biosimilar launches, and policy updates to ensure your biologic access is never interrupted.

Talk to a Pharmacist →